Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data
Functional & Integrative Genomics · 2024-04 · 24 (2)
DOI: 10.1007/s10142-024-01356-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional & Integrative Genomics, online erschienen am 10.04.2024. Verfasst von Songyun Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi Medical Center of Nanjing Medical University, Wuxi, China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Colorectal cancer is a malignant tumor of the digestive system originating from abnormal cell proliferation in the colon or rectum, often leading to gastrointestinal symptoms and severe health issues. Nucleotide metabolism, which encompasses the synthesis of DNA and RNA, is a pivotal cellular biochemical process that significantly impacts both the progression and therapeutic strategies of colorectal cancer Methods For single-cell RNA sequencing (scRNA-seq), five functions were employed to calculate scores related to nucleotide metabolism. Cell developmental trajectory analysis and intercellular interaction analysis were utilized to explore the metabolic characteristics and communication patterns of different epithelial cells. These findings were further validated using spatial transcriptome RNA sequencing (stRNA-seq). A risk model was constructed using expression profile data from TCGA and GEO cohorts to optimize clinical decision-making. Key nucleotide metabolism-related genes (NMRGs) were functionally validated by further in vitro experiments.
Results
In both scRNA-seq and stRNA-seq, colorectal cancer (CRC) exhibited unique cellular heterogeneity, with myeloid cells and epithelial cells in tumor samples displaying higher nucleotide metabolism scores. Analysis of intercellular communication revealed enhanced signaling pathways and ligand-receptor interactions between epithelial cells with high nucleotide metabolism and fibroblasts. Spatial transcriptome sequencing confirmed elevated nucleotide metabolism states in the core region of tumor tissue. After identifying differentially expressed NMRGs in epithelial cells, a risk prognostic model based on four genes effectively predicted overall survival and immunotherapy outcomes in patients. High-risk group patients exhibited an immunosuppressive microenvironment and relatively poorer prognosis and responses to chemotherapy and immunotherapy. Finally, based on data analysis and a series of cellular functional experiments, ACOX1 and CPT2 were identified as novel therapeutic targets for CRC.
Conclusion
In this study, a comprehensive analysis of NMRGs in CRC was conducted using a combination of single-cell sequencing, spatial transcriptome sequencing, and high-throughput data. The prognostic model constructed with NMRGs shows potential as a standalone prognostic marker for colorectal cancer patients and may significantly influence the development of personalized treatment approaches for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuxi Medical Center of Nanjing Medical University, Wuxi, China.
- Department of Neurosurgery, Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
- Department of Lung Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
- Department of General Surgery, Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
- Department of Plastic Surgery, Xiangya Hospital, Central South University, Changsha, China.
- Wuxi Medical Center of Nanjing Medical University, Wuxi, China. Mr_chengchao@126.com.
Zitieren
APA
Zhao, S., Zhang, P., Niu, S., Xie, J., Liu, Y., Liu, Y., Zhao, N., Cheng, C., & Lu, P. (2024). Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data. Functional & Integrative Genomics, 24(2). https://doi.org/10.1007/s10142-024-01356-5
Vancouver
Zhao S, Zhang P, Niu S, Xie J, Liu Y, Liu Y, et al. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data. Functional & Integrative Genomics. 2024;24(2). doi:10.1007/s10142-024-01356-5
BibTeX
@article{Zhao2024,
author = {Zhao, Songyun and Zhang, Pengpeng and Niu, Sen and Xie, Jiaheng and Liu, Yuankun and Liu, Yuan and Zhao, Ning and Cheng, Chao and Lu, Peihua},
title = {Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data},
journal = {Functional & Integrative Genomics},
year = {2024},
volume = {24},
number = {2},
doi = {10.1007/s10142-024-01356-5}
}
EUVIMED